{"id":"W7108740836","doi":"10.1182/blood-2025-5459","title":"Randomised Phase II study of acalabrutinib in combination with R-CHOP treatment for diffuse large B-cell lymphoma confirms safety and unimpaired treatment delivery","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Clinical endpoint; Diffuse large B-cell lymphoma; Chemotherapy regimen; Progression-free survival; International Prognostic Index; Phases of clinical research; Surrogate endpoint; Chemotherapy; Dasatinib; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004141236,0.001627942,0.003183435,0.0006111221,0.0004303917,0.001377108,0.001383367,0.002011933,0.01046207],"category_scores_gemma":[0.002460551,0.0009771418,0.001357821,0.0006513071,0.001679085,0.001265303,0.0006213407,0.003672773,0.001985469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001117915,"about_ca_system_score_gemma":0.00216447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009094761,"about_ca_topic_score_gemma":0.001797089,"domain_scores_codex":[0.9978408,0.001358391,0.00009642373,0.0002539577,0.0001541999,0.0002962498],"domain_scores_gemma":[0.9979373,0.0004169136,0.0004069369,0.0002881184,0.000132327,0.0008184079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9527686,0.02042906,0.0005070977,0.0002728724,0.000379247,0.00007060152,0.00006552623,0.0003241661,0.01016361,0.0001371164,0.001068483,0.01381366],"study_design_scores_gemma":[0.8320311,0.1650353,0.000993808,0.000010588,0.0001188244,0.00003838482,0.00001034863,0.0001678527,0.0006048962,0.0001019961,0.0008773315,0.000009504797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9765627,0.002326191,0.001607125,0.0008356404,0.0005192579,0.01218636,0.002184868,0.0002435554,0.00353436],"genre_scores_gemma":[0.9745731,0.001413384,0.003388108,0.001314003,0.0005664872,0.0109457,0.002438196,0.00008836768,0.005272681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01046207,"threshold_uncertainty_score":0.03499913,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01761737825219514,"score_gpt":0.306223078860797,"score_spread":0.2886057006086019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}